Marimed (MRMD) Gross Profit Growth (1y) (2012 - 2026)

Marimed (MRMD) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 5.06%
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 2.59%
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -18.38%
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn -7.66%
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn -0.34%
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 42.12%
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 14.77%
10 Marimed 25.72 Mn 17.78 Mn 15.28 Mn 1.24%

Historic Data

Download Data
DateValue
Mar 31, 2026 1.24%
Dec 31, 2025 -17.02%
Sep 30, 2025 -2.50%
Jun 30, 2025 -5.19%
Mar 31, 2025 -8.40%
Dec 31, 2024 -26.92%
Sep 30, 2024 -0.33%
Jun 30, 2024 3.25%
Mar 31, 2024 7.04%
Dec 31, 2023 9.52%
Sep 30, 2023 4.17%
Jun 30, 2023 9.14%
Mar 31, 2023 -9.35%
Dec 31, 2022 2.08%
Sep 30, 2022 -11.09%
Jun 30, 2022 -22.68%
Mar 31, 2022 28.74%
Dec 31, 2021 33.32%
Sep 30, 2021 109.46%
Jun 30, 2021 215.13%